PART
III
Item
10. Directors, Executive Officers and Corporate Governance
BOARD
OF DIRECTORS
Set
forth below is certain information regarding the members of the Company’s Board of Directors, including the year in which
each current director became a director of the Company. Each director is entitled to serve until the 2019 Annual Meeting and until
a successor is duly elected and qualified or until his earlier retirement, resignation or removal. The age of each director is
reported as of December 31, 2018.
D.
Kyle Cerminara
, age 41, has been a director since February 2015, the Company’s Chairman since May 2015 and the Company’s
Chief Executive Officer since November 2015. Since April 2012, Mr. Cerminara has also served as the CEO, Co-Founder and Partner
of Fundamental Global Investors, LLC, an SEC registered investment advisor that manages equity and fixed income hedge funds and
is the largest stockholder of the Company. In addition, Mr. Cerminara is Co-Chief Investment Officer of CWA Asset Management Group,
LLC (d/b/a Capital Wealth Advisors), a wealth advisor and multi-family office affiliated with Fundamental Global Investors, LLC,
which position he has held since December 2012. Mr. Cerminara also serves as President and Trustee of StrongVest ETF Trust and
Chief Executive Officer of StrongVest Global Advisors, LLC. StrongVest Global Advisors, LLC, a wholly-owned subsidiary of Ballantyne
Strong, is an investment advisor, and Capital Wealth Advisors is a sub-advisor, to CWA Income ETF, an exchange-traded fund and
series of StrongVest ETF Trust. Mr. Cerminara is a member of the Board of Directors of a number of publicly held companies focused
in the technology, building infrastructure, insurance and communications sectors, including BK Technologies Corporation
(NYSE American: BKTI), a publicly traded manufacturer which recently reorganized into a holding company structure, since July
2015, 1347 Property Insurance Holdings, Inc. (Nasdaq: PIH), a holding company, which, through its subsidiaries, is engaged in
providing property and casualty insurance, since December 2016, Itasca Capital, Ltd. (TSXV: ICL) (formerly Kobex Capital Corp.),
a publicly traded investment firm, since June 2016, and Limbach Holdings, Inc. (Nasdaq: LMB), a company which provides building
infrastructure services, since March 2019. Mr. Cerminara was also appointed chairman of BK Technologies, Inc. in March 2017, chairman
of 1347 Property Insurance Holdings, Inc. in May 2018 and chairman of Itasca Capital Ltd. in June 2018. He also served on the
Board of Directors of Iteris, Inc. (Nasdaq: ITI), a provider of intelligent information solutions for traffic management, from
August 2016 to November 2017, and Magnetek, Inc., a publicly traded manufacturer, in 2015. He also serves on the Board of Directors
of Blueharbor Bank. Prior to co-founding FGI and partnering with Capital Wealth Advisors, Mr. Cerminara was a Portfolio Manager
at Sigma Capital Management, an independent financial adviser, from 2011 to 2012, a Director and Sector Head of the Financials
Industry at Highside Capital Management from 2009 to 2011, and a Portfolio Manager and Director at CR Intrinsic Investors from
2007 to 2009. Before joining CR Intrinsic Investors, Mr. Cerminara was a Vice President, Associate Portfolio Manager and Analyst
at T. Rowe Price from 2001 to 2007 and an Analyst at Legg Mason from 2000 to 2001. Mr. Cerminara received an MBA from the Darden
School of Business at the University of Virginia and a B.S. in Finance and Accounting from the Smith School of Business at the
University of Maryland, where he was a member of Omicron Delta Kappa, an NCAA Academic All American and Co-Captain of the men’s
varsity tennis team. He also completed a China Executive Residency at the Cheung Kong Graduate School of Business in Beijing,
China. Mr. Cerminara holds the Chartered Financial Analyst (CFA) designation. Mr. Cerminara brings to the Board the perspective
of one of the Company’s most significant stockholders. He also has extensive experience in the financial industry, including
investing, capital allocation, finance and financial analysis of public companies, and operational experience as our CEO, which
qualify him to serve on our Board of Directors.
William
J. Gerber
, age 60, served as Chief Financial Officer of TD Ameritrade Holding Corporation (Nasdaq: AMTD) (TD Ameritrade),
a provider of securities brokerage services and related technology-based financial services to retail investors, traders and independent
registered investment advisors, from October 2006 to October 2015. In May 2007, he was named Executive Vice President of TD Ameritrade.
In his role as Chief Financial Officer, he oversaw investor relations, business development, certain treasury functions and finance
operations, including accounting, business planning and forecasting, external and internal reporting, tax and competitive intelligence.
From May 1999 until October 2006, he served as the Managing Director of Finance at TD Ameritrade, during which time he played
a significant role in evaluating merger and acquisition opportunities. Prior to joining TD Ameritrade, he served as Vice President
of Acceptance Insurance Companies, Inc., where he was responsible for all aspects of mergers and acquisitions, investment banking
activity, banking relationships, investor communications and portfolio management. Prior to joining Acceptance, Mr. Gerber spent
eight years with Coopers & Lybrand, now known as PricewaterhouseCoopers, serving as an audit manager primarily focusing on
public company clients. Mr. Gerber was named to Institutional Investor Magazine’s All-America Executive Team as one of the
top three CFOs in the Brokerage, Asset Managers and Exchanges category (2012 and 2013). He was also named a member of the CNBC
CFO Council (2013 and 2014). Since January 2017, he has served on the Board of Directors of Northwestern Mutual Series Fund, a
mutual fund company. He has also served on the Board of Directors of the U.S. holding company for the Royal Bank of Canada since
July 2016 and Streck, Inc., a privately held company, since March 2015. He also serves on the Boys Town National Board of Trustees.
He previously served on the Board of Directors for CTMG Inc., a privately held pharmaceutical testing company. Mr. Gerber holds
a B.B.A. in Accounting from the University of Michigan. Mr. Gerber is also a CPA in the State of Michigan. Mr. Gerber has served
as a director of the Company since May 2015. Mr. Gerber served as Executive Vice President and Chief Financial Officer of TD Ameritrade,
an online brokerage business, for more than eight years and has extensive financial experience, bringing valuable skills to our
Board of Directors.
Colonel
Jack H. Jacobs
, age 73, has served as a director of Ballantyne since July 2018. Colonel Jacobs is the Melcher Family Chair
and Professor of Humanities and Public Affairs at the United States Military Academy at West Point, where he has been teaching
since 2005, and a principal of The Fitzroy Group, Ltd., a firm that specializes in the development of residential real estate
in London and invests both for its own account and in joint ventures with other institutions, for over 20 years. He has served
as an on-air military analyst for NBC News since 2002, where he was an Emmy nominee in 2010 and 2011 and a recipient of the 2011
Murrow Award. Colonel Jacobs was a co-founder and Chief Operating Officer of AutoFinance Group Inc., one of the firms to pioneer
the securitization of debt instruments, from 1988 to 1989; the firm was subsequently sold to KeyBank. He was a Managing Director
of Bankers Trust Corporation, a diversified financial institution and investment bank, where he ran foreign exchange options worldwide
and was a partner in the institutional hedge fund business. Colonel Jacobs’ military career included two tours of duty in
Vietnam where he was among the most highly decorated soldiers, earning three Bronze Stars, two Silver Stars and the Medal of Honor,
the nation’s highest combat decoration. He retired from active military duty as a Colonel in 1987. Colonel Jacobs has been
a member of the board of directors of Paragon Technologies, Inc. (OTCMKTS: PGNT) since 2012, Datatrak International, Inc. (OTCMKTS:
DTRK) since 2016 and Resonant Inc. (Nasdaq: RESN) since 2018. From 2007 to 2012, Colonel Jacobs served as a member of the Board
of Directors of Xedar Corporation, a public company; from June 2006 to 2009, he was a director of Visual Management Systems, a
private company; and he was a director of BioNeutral Group, Inc., a public company, until 2009. From October 17, 2013 to October
28, 2013, Colonel Jacobs served on the board of SED International Holdings, Inc. He was previously a director of Premier Exhibitions,
Inc. Colonel Jacobs is Co-Chairman of the Medal of Honor Foundation and a member of the Board of Trustees of the USO of New York.
He is the author of the book “If Not Now, When?: Duty and Sacrifice in America’s Time of Need.” Colonel Jacobs
received a Bachelor of Arts and a Master’s degree from Rutgers University. Colonel Jacobs’ extensive strategic, operational
and leadership experience, coupled with his service on several public company boards, qualifies him to serve on our Board of Directors.
Lewis
M. Johnson
, age 49, has served as a director of Ballantyne since May 2016. Mr. Johnson has served as the President, Co-Founder
and Partner of Fundamental Global Investors, LLC, an SEC registered investment advisor that manages equity and fixed income hedge
funds and is the largest stockholder of the Company, since April 2012. In addition, Mr. Johnson is Co-Chief Investment Officer
of CWA Asset Management Group, LLC (d/b/a Capital Wealth Advisors), a wealth advisor and multi-family office affiliated with Fundamental
Global Investors, LLC. Prior to co-founding Fundamental Global Investors, LLC and partnering with Capital Wealth Advisors, Mr.
Johnson was a private investor from 2010 to 2012. From 2008 to 2010 Mr. Johnson served as Portfolio Manager and Managing Director
at Louis Dreyfus Highbridge Energy. Previously Mr. Johnson was a Senior Vice President, Portfolio Manager and Analyst at Pequot
Capital from 2006 to 2007. Prior to joining Pequot Capital, he was a Vice President and Analyst at T. Rowe Price from 2000 to
2006. He worked as an Analyst at Capital Research and Management in 1999 and a Vice President at AYSA from 1992 to 1998. Mr. Johnson
received an MBA from the Wharton School of Business at the University of Pennsylvania in addition to a MA in Political Science
and a BA in International Studies from Emory University, where he graduated Magna Cum Laude and was a member of Phi Beta Kappa.
Mr. Johnson is a member of the Board of Directors of a number of publicly held companies, including BK Technologies Corporation
(NYSE American: BKTI), a publicly traded manufacturer which recently reorganized into a holding company structure, since May 2016,
1347 Property Insurance Holdings, Inc. (Nasdaq: PIH), a holding company, which, through its subsidiaries, is engaged in providing
property and casualty insurance, since April 2017, and Itasca Capital, Ltd. (TSXV: ICL) (formerly Kobex Capital Corp.), a publicly
traded investment firm, since June 2018. Mr. Johnson was also appointed co-chairman of 1347 Property insurance Holdings, Inc.
in May 2018 and co-chairman of BK Technologies, Inc. in June 2018. Mr. Johnson brings to the Board the perspective of one of the
Company’s most significant stockholders. He has extensive experience in the financial industry, including investing, capital
allocation, finance and financial analysis of public companies.
Charles
T. Lanktree
, age 69, has served as Chief Executive Officer of Eggland’s Best, LLC, a joint venture between Eggland’s
Best, Inc. and Land O’Lakes, Inc. distributing nationally branded eggs, since 2012 and also served as its President from
2012 to 2018. Since 1997, Mr. Lanktree has served as President and Chief Executive Officer of Eggland’s Best, Inc., a franchise-driven
consumer egg business, where he previously served as the President and Chief Operating Officer from 1995 to 1996 and Executive
Vice President and Chief Operating Officer from 1990 to 1994. Mr. Lanktree currently serves on the Board of Directors of Eggland’s
Best, Inc. and several of its affiliates. He has also served on the board of directors of BK Technologies Corporation (NYSE American:
BKTI), a publicly traded manufacturer which recently reorganized into a holding company structure, since March 2017. From 2010
to 2013, he served on the Board of Directors of Eurofresh Foods, Inc., a privately held company, and from 2004 to 2013, he was
on the Board of Directors of Nature’s Harmony Foods, Inc. Prior to joining Eggland’s Best, Inc., Mr. Lanktree served
as the President and Chief Executive Officer of American Mobile Communications, Inc. from 1987 to 1990 and as the President and
Chief Operating Officer of Precision Target Marketing, Inc. from 1985 to 1987. From 1976 to 1985, he held various executive-level
marketing positions with The Grand Union Company and Beech-Nut Foods Corporation. Mr. Lanktree received an MBA from the University
of Notre Dame and a B.S. in Food Marketing from St. Joseph’s College. He also served in the U.S. Army and U.S. Army Reserves
from 1971 to 1977. Mr. Lanktree has served as a director of Ballantyne since May 2015. Mr. Lanktree’s 25 years of experience
in consumer marketing and retail operations and his extensive experience as a Chief Executive Officer, coupled with his knowledge
and insight of the retail industry, including distribution and franchising operations, qualifies him to serve on our Board of
Directors.
Robert
J. Roschman
, age 53, has been an owner of Triple R. Associates, Ltd., a real estate firm with over 100 properties leased to
fast food, distribution and retail tenants, since 1992. Mr. Roschman also holds ownership interests in several development properties
throughout Florida. Mr. Roschman currently serves on the Board of Directors of Giant Holdings, Inc., a privately held federally
chartered bank with an Internet division, which he founded in 1998. From 1987 to 2000, Mr. Roschman was a Co-Founder and Vice
President of Snapps Restaurants, Inc., a 76-store fast food restaurant which merged into Rally’s Hamburgers, Inc. From 1983
until 1997, he served as a shareholder of Charter Bank in Delray Beach, Florida, which merged into Southtrust Bank in 1997. Mr.
Roschman received a B.S. from Florida State University. He has served as a director of the Company since May 2015. Mr. Roschman
brings over 30 years of experience as an investor in multiple lines of business, including real estate, franchising, distribution,
banking and retail. Mr. Roschman’s extensive experience as an investor and in managing and overseeing multiple businesses
is valuable for evaluating strategic opportunities and qualifies him to serve on our Board of Directors.
Ndamukong
Suh
, age 31, is an independent private investor. Mr. Suh holds ownership interests in several real estate development projects
across Michigan, Nebraska, Oregon and Colorado. Mr. Suh is the Founder and a director of the Ndamukong Suh Family Foundation.
He is also a professional athlete, currently a free agent in the National Football League (“NFL”). Prior to becoming
a free agent, he was with the NFL’s Los Angeles Rams in 2018, Miami Dolphins from 2015 to 2017 and Detroit Lions from 2010
to 2014. He currently serves on the Board of Directors of Ember Technologies, a privately held manufacturer and designer of patented
temperature adjustable dishware and drinkware. Mr. Suh holds a Bachelor’s degree in Engineering focused on Construction
Management from the University of Nebraska. Mr. Suh has served as a director of Ballantyne since January 2016. Our Board of Directors
believes that Mr. Suh’s well cultivated business and personal network adds unique value to the Company, which, coupled with
his extensive experience as an investor, allows him to evaluate strategic opportunities and qualifies him to serve on our Board
of Directors.
CORPORATE
GOVERNANCE
The
Board of Directors operates pursuant to the provisions of the Certificate of Incorporation and Bylaws and has also adopted several
corporate governance policies to address significant corporate governance issues. Our Code of Ethics, Audit Committee Charter,
Nominating and Corporate Governance Committee Charter, and Compensation Committee Charter are available on our website at
www.ballantynestrong.com
under the tab “Investors” and then the “Corporate Governance” tab.
Board
Leadership Structure and Role of the Board in Risk Oversight
D.
Kyle Cerminara is the Company’s Chief Executive Officer and Chairman of the Board of Directors. Mr. Cerminara represents
the Company’s largest stockholder, which, together with its affiliates, holds 34.9% of the voting and economic interest
in the Company. As such, Mr. Cerminara may be deemed to be the Company’s controlling stockholder. At this time, it is the
Board’s view that a controlling stockholder who is active in the business, as is currently the case, should hold both the
roles of Chief Executive Officer and Chairman, setting the tone of the organization, having the ultimate responsibility for all
of the Company’s operating and strategic functions, and providing unified leadership and direction to the Board of Directors
and the Company’s executive management. Further, the Board believes that Mr. Cerminara, as the Chief Executive Officer and
Chairman, is in the best position to be aware of major issues facing the Company on a day-to-day basis, and is in the best position
to identify key risks and developments facing the Company to be brought to the Board’s attention.. The Board of Directors
has not named a lead independent director, but receives strong leadership from all of its members. Our Board committees consist
of only independent members, and our independent directors meet at least annually in executive session without the presence of
non-independent directors and management. In addition, our directors take active and substantial roles in the activities of our
Board at the full board meetings. They are able to propose items for board meeting agendas, and the Board’s meetings include
time for discussion of items not on the formal agenda. Our Board believes that this open structure, as compared to a system in
which there is a designated lead independent director, facilitates a greater sense of responsibility among our directors and facilitates
active and effective oversight by the independent directors of the Company’s operations and strategic initiatives, including
any risks.
One
of the Board’s key functions is informed oversight of the Company’s risk management process. The Board does not have
a standing risk management committee, but rather administers this oversight function directly through the Board as a whole, as
well as through various Board standing committees that address risks inherent in their respective areas of oversight. In particular,
the Board is responsible for monitoring and assessing strategic and operational risk exposure. The Audit Committee has the responsibility
to consider and discuss major financial risk exposures and the steps management has taken to monitor and control these exposures,
including guidelines and policies to govern the process by which risk assessment and management is undertaken. The Audit Committee
also provides oversight of the performance of the internal audit function. The Nominating and Corporate Governance Committee monitors
the effectiveness of the Company’s corporate governance policies and the selection of prospective Board members and their
qualifications. The Compensation Committee, in conjunction with the Audit Committee, assesses and monitors whether any of the
Company’s compensation policies and programs have the potential to encourage excessive risk-taking. Like all businesses,
we also face threats to our cybersecurity, as we are reliant upon information systems and the Internet to conduct our business
activities. In light of the pervasive and increasing threat from cyberattacks, the Board believes oversight of this risk is appropriately
allocated to the Audit Committee. The Audit Committee, with input from management, assesses the Company’s cybersecurity
threats and the measures implemented by the Company to mitigate and prevent cyberattacks and periodically reports on the Company’s
cybersecurity program to the Board.
Typically,
the entire Board meets with management and the applicable Board committees at least annually to evaluate and monitor respective
areas of oversight. Both the Board as a whole and the various standing committees receive periodic reports from individuals responsible
for risk management, as well as incidental reports as matters may arise. It is the responsibility of the committee chairs to report
findings regarding material risk exposures to the Board as quickly as possible. The Board’s role in risk oversight does
not affect the Board’s leadership structure. However, our Board’s leadership structure supports such risk oversight
by combining the Chairman position with the Chief Executive Officer position, the person with primary corporate responsibility
for risk management.
Board
Independence
The
Board of Directors is composed of a majority of independent directors as defined by the listing requirements of the NYSE American.
The Board of Directors has determined that Messrs. Gerber, Jacobs, Lanktree, Roschman and Suh are independent directors of the
Company under the listing standards adopted by the NYSE American. The Board of Directors also determined that Messrs. Samuel C.
Freitag and James C. Shay, who served on the Board during 2018, were independent under the same listing standards. In making these
independence determinations, the Board considered all of the factors that automatically compromise director independence as specified
in the NYSE American’s listing standards and determined that none of those conditions existed. In addition, the Board considered
whether any direct or indirect material relationship, beyond those factors that automatically compromise director independence,
existed between those directors, their immediate family members, or their affiliated entities, on the one hand, and us and our
subsidiaries, on the other hand. The Board determined, for those directors identified as independent above, that any relationship
that existed was not material and did not compromise that director’s independence. Our independent directors meet in an
executive session at least once per year.
Communication
to the Board
Stockholders
and other interested parties wishing to communicate with the Board of Directors or a specific director may do so by delivering
written correspondence to the Corporate Secretary of the Company at: Attn: Corporate Secretary, Ballantyne Strong, Inc., 11422
Miracle Hills Drive, Suite 300, Omaha, NE 68154. The Corporate Secretary will present the communication to the appropriate director
or directors.
Board
and Committee Meeting Attendance
The
Board of Directors held 13 meetings during 2018. Each current director attended at least seventy-five percent (75%) of the aggregate
of the total number of board meetings held during the period for which he has been a director and the total number of meetings
held by all committees of the Board on which he served during the periods that he served.
Mr.
Cerminara was the only director that attended the 2018 Annual Meeting. Other than Mr. Cerminara, none of the directors are expected
to attend the Annual Meeting.
Hedging
and Pledging Policy
The
Company prohibits the Company’s officers, other employees and directors from hedging or pledging the Company’s shares.
BOARD
COMMITTEES
The
Board has an Audit Committee, a Nominating and Corporate Governance Committee and a Compensation Committee. The current charters
for each of the Committees are available on our website
www.ballantynestrong.com
under the “Investors” tab
and then the “Corporate Governance” tab. The members of the Board committees, as of December 31, 2018 and the date
of this Form 10-K/A, are identified in the following table:
Director
|
|
Audit
Committee
|
|
Compensation
Committee
|
|
Nominating
and
Corporate Governance
Committee
|
D. Kyle Cerminara
(1)
|
|
|
|
|
|
|
William J. Gerber
|
|
Chair
|
|
X
|
|
|
Colonel Jack H. Jacobs
(2)
|
|
X
|
|
|
|
Chair
|
Lewis M. Johnson
(3)
|
|
|
|
|
|
|
Charles T. Lanktree
|
|
|
|
Chair
|
|
|
Robert J. Roschman
|
|
|
|
X
|
|
X
|
Ndamukong Suh
|
|
|
|
|
|
X
|
(1)
Chairman of the Board.
(2)
Colonel Jacobs was appointed to the Audit Committee and Compensation Committee effective July 11, 2018 and as the Chair of the
Nominating and Corporate Governance Committee effective September 7, 2018.
(3)
Mr. Johnson was appointed as Chair of the Nominating and Corporate Governance Committee effective July 11, 2018; his service on
the committee ended effective September 7, 2018.
Audit
Committee
The
Audit Committee of the Company’s Board of Directors consists of directors Gerber (Chair) and Jacobs, who are independent
for purposes of serving on the committee under the SEC’s rules and NYSE American’s listing requirements. As a smaller
reporting company, the Company is only required to maintain an audit committee of two independent members. The Audit Committee
acts under a written charter adopted by the Board of Directors. All Audit Committee members are financially literate. The Board
of Directors has determined that Mr. Gerber is an “audit committee financial expert” as defined by Item 407(d)(5)(ii)
of Regulation S-K under the Securities Exchange Act of 1934, as amended (the “Exchange Act”). The Audit Committee
assists the Board of Directors in fulfilling its responsibilities for oversight of the quality and integrity of the accounting,
auditing and reporting practices of the Company, and performs such other duties as are directed by the Board. The Committee’s
role includes a particular focus on the qualitative aspects of financial reporting to stockholders, and on the Company’s
processes to manage business and financial risk, and for compliance with significant applicable legal, ethical and regulatory
requirements. At least annually and generally on a quarterly basis, the Committee reviews and discusses matters separately with
management of the Company and with the Company’s independent auditors.
The
Committee is directly responsible for the appointment of the independent registered public accounting firm engaged to prepare
and issue an audit report on the financial statements of the Company and periodically reviews and evaluates their performance
and independence from management. All audit and permitted non-audit services are pre-approved by the Committee. The Committee
has delegated the responsibility of approving proposed non-audit services that arise between Committee meetings to the Chairman,
provided that the decision to approve the services is presented for ratification at the next scheduled Committee meeting. During
2018, the Committee held five meetings.
Compensation
Committee
The
Compensation Committee of the Company’s Board of Directors consists of directors Lanktree (Chair), Gerber and Roschman.
All members of the Committee are independent for purposes of serving on the committee under the NYSE American’s listing
requirements and applicable SEC and tax regulations. The Compensation Committee acts under a written charter adopted by the Board
of Directors. The Committee functions include, but are not limited to:
|
●
|
Determining
the compensation of the Chief Executive Officer;
|
|
|
|
|
●
|
Overseeing
all other executive officers’ compensation, including salary and payments under the Company’s incentive and stock
plans;
|
|
|
|
|
●
|
Administering
the Company’s stock compensation plans, including approving all individual grants and awards under these plans; and
|
|
|
|
|
●
|
Reviewing
compensation for non-employee directors and recommending changes to the Board.
|
The
Committee may delegate its authority to a subcommittee of its members. Further discussion of the Compensation Committee can be
found under the heading “Compensation Discussion and Analysis.” The Committee held three meetings during 2018.
Nominating
and Corporate Governance Committee
The
members of the Nominating and Corporate Governance Committee are directors Jacobs (Chair), Roschman and Suh. All members of the
Nominating and Corporate Governance Committee are independent for purposes of serving on the committee under the NYSE American’s
listing requirements. The Nominating and Corporate Governance Committee acts under a written charter adopted by the Board of Directors.
The functions of the Committee include, among other items, overseeing all aspects of the Company’s corporate governance
functions including compliance with significant legal, ethical and regulatory requirements. The Nominating and Corporate Governance
Committee also reports to, and assists, the Board of Directors in identifying individuals for membership to the Board and recommends
to the Board the director nominees for the next Annual Meeting of Stockholders. The Nominating and Corporate Governance Committee
held one meeting during 2018.
Director
Nomination Process
—The Nominating and Corporate Governance Committee believes that the Company is well-served by
its current directors. In the ordinary course, absent special circumstances or a material change in the criteria for Board membership,
the Committee will re-nominate incumbent directors who continue to be qualified for Board service and are willing to continue
as directors. If an incumbent director is not standing for re-election or if a vacancy occurs between annual stockholder meetings,
the Committee will seek out potential candidates for Board appointment who meet the criteria for selection as a nominee and have
the specific qualities or skills being sought. Director candidates will be selected based upon input from the members of the Board,
senior management of the Company and, if the Committee deems appropriate, a third-party search firm.
Candidates
will be chosen for their ability to represent all of the stockholders, and for their character, judgment, fairness and overall
ability. As a group, they are expected to set the appropriate policy for the Company, and to bring to the Board of Directors broad
experience in business matters and an insight and awareness of the appropriate and ever-changing role that corporations should
have in society. Because the advice of those facing similar issues is of particular value, executive officers of other corporations
are desirable candidates. Ballantyne does not have a set policy or process for considering “diversity”, however that
term may be defined, in identifying nominees. However, the Nominating and Governance Committee strives to identify and recruit
individuals whose diverse talents, experiences and backgrounds enhance the inclusive environment in which the Board currently
functions. The Committee relies upon its judgment of the foregoing general criteria and the following personal criteria in selecting
candidates for nomination to the Board of Directors:
|
●
|
Independence
and absence of conflicts of interest;
|
|
|
|
|
●
|
Honesty,
integrity and accountability;
|
|
|
|
|
●
|
Substantial
business experience with a practical application to the Company’s needs;
|
|
|
|
|
●
|
Willingness
to ask tough questions in a constructive manner that adds to the decision making process of the Board;
|
|
●
|
Demonstrated
ability to think strategically and make decisions with a forward looking focus;
|
|
|
|
|
●
|
Ability
to assimilate relevant information on a broad range of topics;
|
|
|
|
|
●
|
Willingness
to express independent thought;
|
|
|
|
|
●
|
Team
player;
|
|
|
|
|
●
|
Willingness
to make a strong commitment of time and attention to the Board’s processes and affairs; and
|
|
|
|
|
●
|
Ability
to commit to Company stock ownership.
|
The
Nominating and Corporate Governance Committee will also consider proposals for nominees for director from stockholders which are
made in writing to the Corporate Secretary of the Company and comply with Bylaw requirements. The recommendation must contain
sufficient background information concerning the nominee to enable a proper judgment to be made as to his or her qualifications.
Recommendations must also include a written statement from the candidate expressing a willingness to serve.
EXECUTIVE
OFFICERS
The
following is a list of the names and ages of the current executive officers of the Company, their business history and their term
of office with the Company. The age of each executive officer is reported as of December 31, 2018.
Name
|
|
Age
|
|
Position
and Principal Occupation
|
|
Officer
Since
|
D.
Kyle Cerminara
|
|
41
|
|
Director
since February 2015, Chairman since May 2015 and Chief Executive Officer since November 2015. CEO, Co-Founder and Partner
of Fundamental Global Investors, LLC and Co-Chief Investment Officer of Capital Wealth Advisors. For additional information,
see the section titled “Board of Directors.”
|
|
2015
|
|
|
|
|
|
|
|
Mark
D. Roberson
|
|
53
|
|
Executive
Vice President and Chief Financial Officer. Mr. Roberson brings an extensive background in executive leadership, operations,
corporate finance, SEC reporting, treasury, and mergers & acquisitions. He previously served as Chief Operations Officer
of Chanticleer Holdings, Inc. a NASDAQ -listed restaurant operating company, and as Chief Executive Officer and Chief Financial
Officer of PokerTek, Inc., a NASDAQ-listed gaming technology company, and previously held positions of increasing responsibility
at Curtiss-Wright, Inc., a NYSE-listed aerospace and defense contractor, Krispy Kreme Doughnut Corporation, a NYSE-listed
fast-casual restaurant franchisor and operator, and LifeStyle Furnishings International, a $2 billion private equity backed
furniture manufacturer. Mr. Roberson is a CPA who started his career with Ernst & Young and PricewaterhouseCoopers. He
earned an MBA from Wake Forest University, a BS in Accounting from UNC-Greensboro and a BS in Economics from Southern Methodist
University. He has served on the Board of Directors of Cynergistek, Inc. (NYSE American: CTEK), a cybersecurity and information
management consulting firm, since May 2016, where he chairs the Audit and Compensation Committees.
|
|
2018
|
|
|
|
|
|
|
|
Ray
F. Boegner
|
|
69
|
|
President
of Strong Cinema; previously Senior Vice President and Senior Vice President of Sales; Vice President of Sales prior to November
1996; joined Company in 1985.
|
|
1997
|
ADDITIONAL
INFORMATION
Compliance
with Section 16(a) of the Exchange Act
Section
16(a) of the Exchange Act requires the Company’s executive officers and directors, and persons who beneficially own more
than 10% of the Company’s stock, to file initial reports of ownership and reports of changes in ownership with the SEC.
Ballantyne believes that all persons subject to these reporting requirements filed the required reports on a timely basis during
2018.
Code
of Ethics
Our
board of directors has adopted the Code of Ethics that applies to all of our directors, officers and employees, including our
principal executive officer, principal financial officer and principal accounting officer. The Code of Ethics is posted on our
Internet website,
www.ballantynestrong.com/investors
, under the “Corporate Governance” tab, and is available
free of charge, upon request to Corporate Secretary, 11422 Miracle Hills Drive, Suite 300, Omaha, NE 68154; telephone number:
(402) 453-4444.
Any
amendment to, or waiver from, the Code of Ethics applicable to our directors and executive officers will be disclosed in a current
report on Form 8-K within four business days following the date of the amendment or waiver unless the rules of the NYSE American
then permit website posting of such amendments and waivers, in which case we would post such disclosures on our Internet website.
Item
11. Executive Compensation
EXECUTIVE
COMPENSATION
Introduction
In
this section of the Form 10-K/A, we disclose our executive compensation for our Named Executive Officers (also referred to as
the “NEOs”), consisting of our principal executive officer, the two other individuals who were serving as executive
officers at the end of 2018, and one other individual who served as an executive officer during 2018. Our NEOs for 2018 are as
follows:
|
●
|
D.
Kyle Cerminara, Chairman and Chief Executive Officer;
|
|
|
|
|
●
|
Mark
D. Roberson, Executive Vice President and Chief Financial Officer (since November 16, 2018);
|
|
|
|
|
●
|
Lance
V. Schulz, former Senior Vice President, Chief Financial Officer and Treasurer (from March 29, 2017 until November 16, 2018);
and
|
|
|
|
|
●
|
Ray
F. Boegner, President of Strong Cinema.
|
Base
Salaries
On
February 28, 2017, in recognition of their contributions and long-term value to the Company and internal pay equity considerations,
the Compensation Committee approved increases to the annual base salaries of Messrs. Cerminara and Boegner for 2017. Mr. Cerminara’s
2017 annual base salary was increased from $150,000 to $225,000 and Mr. Boegner’s 2017 annual base salary was increased
from $225,000 to $275,000. The adjustments were effective as of March 1, 2017. As part of Mr. Boegner’s salary increase,
his auto allowance of $1,000 per month was eliminated effective as of March 1, 2017. The base salaries for Messrs. Cerminara and
Boegner remained unchanged for 2018.
Mr.
Roberson receives a base salary of $250,000, which salary was negotiated as part of his employment agreement at the time of his
hiring as Executive Vice President and Chief Financial Officer of the Company, effective November 16, 2018.
Mr.
Schulz received a base salary of $250,000 during his tenure as Senior Vice President, Chief Financial Officer and Treasurer of
the Company from March 29, 2017 to November 16, 2018. The salary was negotiated as part of his employment agreement at the time
of his hiring as Senior Vice President, Chief Financial Officer and Treasurer. Since November 16, 2018, Mr. Schulz has provided
consulting services to the Company at the rate of $26,683 per month, pro-rated for any partial month, pursuant to the terms of
a consulting agreement. On March 26, 2019, Mr. Schulz and the Company agreed to extend the consulting agreement beyond March 31,
2019 on a month-to-month basis at the same rate, pro-rated for any partial month. Either party may terminate the consulting agreement
at any time.
Discretionary
Bonuses
After
considering a number of factors, including Company performance, the Compensation Committee determined not to pay any discretionary
cash bonuses to executive officers for 2018 or 2017. The Compensation Committee determined to award equity grants to certain executive
officers as described below.
Long-Term
Incentives
We
use long-term incentive equity awards as a part of our executive compensation program, in order to incentivize and reward the
achievement of longer-term strategic objectives and align the financial interests of the Company’s executive officers with
those of the Company’s stockholders. The Company’s long-term incentive program for our NEOs has consisted of restricted
stock awards (or “RSAs”), restricted stock units (or “RSUs”) and nonqualified stock options. Each such
type of award, and the reasons it is used, is described below. At the Company’s 2017 Annual Meeting, the Company’s
stockholders approved the Company’s 2017 Omnibus Equity Compensation Plan, as the successor to our 2010 Long Term Incentive
Plan and 2014 Non-Employee Directors’ Restricted Stock Plan, and long-term incentive awards granted after the 2017 Annual
Meeting have been made under the 2017 Omnibus Equity Compensation Plan.
|
Restricted
Stock Awards.
RSAs represent the transfer of ownership of a certain number of shares of the Company’s common
stock, subject to restrictions on transfer and a substantial risk of forfeiture based on the recipient’s continued employment
by the Company during the applicable vesting period set out in the award agreement. RSAs are designed primarily to encourage
retention of executive officers and key employees.
|
|
|
|
Restricted
Stock Units.
RSUs represent a right to receive a specific number of units at the end of the specified period. Each
recipient of RSUs has no rights as a stockholder through such RSUs during the restriction period of his RSUs. Settlement of
an RSU award is made in cash, shares of stock or some combination thereof, as specified in the applicable award agreement.
RSUs are designed to provide retention incentives to our executive officers and key employees.
|
|
|
|
Nonqualified
Stock Options.
Nonqualified stock options represent an option to purchase shares of the Company’s common stock
at an option price equal to the closing price on the NYSE American of the Company’s common stock on the grant date.
The stock options are designed to motivate executives to increase stockholder value as the stock options will only have value
if our stockholders also benefit from increasing stock prices.
|
2018
Equity Grants
On
January 26, 2018, the Compensation Committee approved grants of stock options and RSUs to Messrs. Cerminara, Schulz and Boegner.
Each of these executives was granted a stock option to purchase 50,000 shares of the Company’s common stock, at an exercise
price of $4.70 per share, under the Company’s 2017 Omnibus Equity Compensation Plan. The stock options have a ten-year term
and become exercisable in one-fifth annual installments, beginning on the first anniversary of the grant date, subject to continued
employment. Mr. Schulz’s stock options were forfeited upon his resignation from the Company effective November 16, 2018.
The
RSU awards to Messrs. Cerminara, Schulz and Boegner each covered 40,000 shares of the Company’s common stock, and those
RSUs vest in one-third annual installments, beginning on the first anniversary of the grant date, subject to continued employment.
As part of Mr. Schulz’s consulting agreement entered into in connection with his resignation, the Company agreed to amend
Mr. Schulz’s award agreement to provide that one-third of his 40,000 unvested RSUs would vest on January 26, 2019 and two-thirds
would vest on March 31, 2019, subject to Mr. Schulz remaining in the continuous service of the Company through the applicable
vesting dates.
On
December 4, 2018, as a signing bonus, the Company granted to Mr. Roberson 50,000 RSUs pursuant to the Company’s 2017 Omnibus
Equity Compensation Plan, vesting in one-third annual installments beginning on the first anniversary of the grant date, subject
to continued employment, and stock options to purchase 40,000 shares of the Company’s common stock at an exercise price
of $2.25 per share pursuant to the Company’s 2017 Omnibus Equity Compensation Plan. The stock options have a ten-year term
and become exercisable in one-fifth annual installments, beginning on the first anniversary of the grant date, subject to continued
employment.
2017
Equity Grants
On
February 28, 2017, the Compensation Committee approved grants of stock options and restricted stock to Messrs. Cerminara and Boegner
under the 2010 Long-Term Incentive Plan based on management’s recommendations and the officers’ performance. The Committee
granted 60,000 and 40,000 stock options to Messrs. Cerminara and Boegner, respectively, to purchase common shares of the Company
at the exercise price of $6.50 per share under the 2010 Long-Term Incentive Plan. These options have a ten-year term and become
exercisable in one-fifth annual installments, beginning on the first anniversary of the grant date, subject to continued employment.
The options are subject to the terms and conditions of their respective Stock Option Agreements.
In
recognition of their contributions to the business, Mr. Cerminara also received 60,000 restricted shares of the Company’s
common stock and Mr. Boegner received 10,000 restricted shares of the Company’s common stock, in each case pursuant to the
2010 Long-Term Incentive Plan and the terms and conditions of their respective Restricted Stock Agreements. These shares vest
in one-third annual installments, beginning on the first anniversary of the grant date, subject to continued employment.
As
a signing bonus and pursuant to the terms of his Employment Agreement, on April 7, 2017 the Company granted Mr. Schulz a stock
option to purchase 40,000 shares of the Company at an exercise price of $6.30 per share pursuant to the Company’s 2010 Long-Term
Incentive Plan. Upon his resignation from the Company effective November 16, 2018, Mr. Schulz immediately forfeited 30,000 unvested
options and, following a period of thirty days from the effective date of his resignation, forfeited the right to exercise 10,000
options.
401(k)
Retirement Plan
The
Company’s executive officers are able to participate in the Company’s Retirement and Savings 401(k) Plan (the “401(k)
Plan”), which is a combination savings and profit sharing plan designed to qualify under Section 401 of the U.S. Internal
Revenue Code. Participation in the 401(k) Plan is generally available to all Ballantyne employees on the same terms. Each participant
may defer up to 100% of his or her compensation. The Company may make a discretionary matching contribution equal to a uniform
percentage of salary. Each year the Company determines the amount of the discretionary percentage. In 2018, the Company matched
50% of the amount deferred up to 6% of each participating employee’s contribution. Employee contributions to the 401(k)
Plan are non-forfeitable. Employer contributions vest annually over three years on the employee’s employment anniversary.
Benefits may be distributed to participants or their beneficiaries, as the case may be, in the event of a participant’s
death, retirement or other termination of service, or, if the participant so requests, on reaching age 59½. Participants
may be eligible to withdraw benefits in case of hardship.
Contributions
to the 401(k) Plan made by the Company on behalf of the NEOs are included in the 2018 Summary Compensation Table.
Employment
Agreements
The
Company currently has written employment agreements with Messrs. Boegner and Roberson. The Company also had a written employment
agreement with, and, upon his resignation effective November 16, 2018, has a consulting agreement with, Mr. Schulz. The material
provisions of these employment and consulting agreements are discussed below.
Mr.
Boegner’s employment agreement with the Company, which was entered into on February 14, 2012, provides for a base salary,
subject to annual review and adjustment, and Mr. Boegner’s eligibility to participate in and/or receive other benefits under
compensation plans provided to other executive employees of the Company, including an automobile allowance (which allowance was
eliminated effective as of March 1, 2017). He is eligible for performance-based compensation in the form of an annual bonus and
is eligible to receive awards, in the Compensation Committee’s discretion, under the Company’s long-term incentive
plans. Pursuant to his employment agreement, in the event that his employment is terminated by Ballantyne without good cause or
by Mr. Boegner for good reason, as these terms are defined in the agreement, then he will receive his base salary for period equal
to three (3) weeks for each year that he has been employed by the Company. In addition, Ballantyne will pay for or reimburse Mr.
Boegner for the cost of health insurance during this same period. For more information on the terms of Mr. Boegner’s employment
agreement, see “Potential Payments Upon Termination or Change-in-Control— Employment Agreements.”
Mr.
Roberson’s employment agreement with the Company, which was entered into on November 7, 2018, provides for an annual base
salary of $250,000, subject to annual review and adjustment, and he is eligible for performance-based compensation in the form
of an annual bonus targeted at $150,000, payable partly in cash and partly through equity awards as determined by the Compensation
Committee. The bonus will be subject to the achievement of performance metrics and other criteria as determined by the Compensation
Committee. As a signing bonus, the Company granted to Mr. Roberson 50,000 restricted stock units pursuant to the Company’s
2017 Omnibus Equity Compensation Plan, vesting over a period of three years from the date of grant, and a stock option to purchase
40,000 shares of the Company’s common stock pursuant to the Company’s 2017 Omnibus Equity Compensation Plan, which
option will vest over a period of five years from the date of grant. Mr. Roberson is also eligible to participate in the Company’s
401(k), medical, dental and vision plans and certain other benefits available generally to employees of the Company. The employment
agreement also contains customary non-competition and non-solicitation covenants. Mr. Roberson’s employment agreement does
not provide for any specified severance benefits.
Mr.
Schulz’s employment agreement with the Company, which was entered into on March 23, 2017, provided for an annual base salary
of $250,000 and a target annual bonus opportunity of $150,000. Any annual bonus earned based on the achievement of performance
metrics and other criteria established by the Compensation Committee was payable partly in cash and partly through equity awards,
as determined by the Compensation Committee. The employment agreement also provided Mr. Schulz with a signing bonus in the form
of a stock option to purchase 40,000 shares of the Company’s common stock, which option was scheduled to vest over a period
of four years from the date of grant. Pursuant to his employment agreement, Mr. Schulz was eligible to participate in the Company’s
401(k), medical, dental and vision plans and certain other benefits available generally to employees of the Company. The employment
agreement also contained customary non-competition and non-solicitation covenants. Mr. Schulz’s employment agreement did
not provide for any specified severance benefits.
In
connection with his resignation effective November 16, 2018, the Company entered into a consulting agreement with Mr. Schulz.
Pursuant to the consulting agreement, Mr. Schulz agreed to provide consulting services to the Company through March 31, 2019,
at the rate of $26,683 per month, pro-rated for any partial month. The Company agreed to amend Mr. Schulz’s award agreement
for 40,000 RSUs held by Mr. Schulz to provide that one-third of the RSUs would vest on January 26, 2019, and two-thirds of the
RSUs would vest on March 31, 2019, subject to Mr. Schulz remaining in the continuous service of the Company through the applicable
vesting dates. If the Company terminated the consulting agreement prior to March 31, 2019 for any reason other than cause, as
defined in the Company’s 2017 Omnibus Equity Compensation Plan, all unvested RSUs outstanding as of the date of such termination
would immediately vest. If the Company terminated the consulting agreement for cause, or if Mr. Schulz terminated the consulting
agreement for any reason, prior to March 31, 2019, all unvested RSUs outstanding as of the date of such termination would be immediately
forfeited. The Company also agreed to pay the employer contribution amount of COBRA premiums through December 31, 2019, if Mr.
Schulz enrolled in such post-employment coverage under the Company’s health plan, subject to Mr. Schulz’s continued
service pursuant to the consulting agreement through March 31, 2019. On March 26, 2019, Mr. Schulz and the Company agreed to extend
the consulting agreement beyond March 31, 2019 on a month-to-month basis at the same rate, pro-rated for any partial month. Either
party may terminate the consulting agreement at any time.
Executive
Compensation Tables
The
following table sets forth information regarding all forms of compensation earned by the Company’s Named Executive Officers
during the last two fiscal years. Messrs. Cerminara and Boegner were employed by the Company during all of fiscal 2017 and 2018.
Mr. Schulz served as Chief Financial Officer from March 29, 2017 until his resignation effective November 16, 2018, at which time
Mr. Roberson was appointed to the position.
2018
Summary Compensation Table
Name
and
Principal Position
|
|
Year
|
|
|
Salary
($)
|
|
|
Bonus
($)
|
|
|
Stock
Awards
($)
(4)
|
|
|
Option
Awards
($)
(4)
|
|
|
Non-Equity
Incentive Plan Compensation
($)
|
|
|
All
Other Compensation
($)
(12)
|
|
|
Total
($)
|
|
D. Kyle
Cerminara
(1)
|
|
|
2018
|
|
|
|
225,000
|
|
|
|
—
|
|
|
|
188,000
|
(5)
|
|
|
91,074
|
(8)
|
|
|
—
|
|
|
|
5,691
|
|
|
|
509,765
|
|
Chairman and CEO
|
|
|
2017
|
|
|
|
210,577
|
|
|
|
—
|
|
|
|
390,000
|
(6)
|
|
|
144,577
|
(9)
|
|
|
—
|
|
|
|
5,518
|
|
|
|
750,672
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Mark D. Roberson
(2)
|
|
|
2018
|
|
|
|
25,000
|
|
|
|
—
|
|
|
|
112,500
|
(7)
|
|
|
37,223
|
(10)
|
|
|
—
|
|
|
|
85
|
|
|
|
174,808
|
|
EVP and CFO
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Lance V. Schulz
(3)
|
|
|
2018
|
|
|
|
225,962
|
|
|
|
—
|
|
|
|
188,000
|
(5)
|
|
|
91,074
|
(8)
|
|
|
—
|
|
|
|
65,620
|
|
|
|
570,656
|
|
Former SVP, Treasurer and CFO
|
|
|
2017
|
|
|
|
185,577
|
|
|
|
—
|
|
|
|
—
|
|
|
|
93,591
|
(11)
|
|
|
—
|
|
|
|
5,917
|
|
|
|
285,085
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ray F. Boegner
|
|
|
2018
|
|
|
|
275,000
|
|
|
|
—
|
|
|
|
188,000
|
(5)
|
|
|
91,074
|
(8)
|
|
|
—
|
|
|
|
9,193
|
|
|
|
563,267
|
|
President of Strong Cinema
|
|
|
2017
|
|
|
|
265,385
|
|
|
|
—
|
|
|
|
65,000
|
(6)
|
|
|
96,385
|
(9)
|
|
|
—
|
|
|
|
11,282
|
|
|
|
438,052
|
|
(1)
|
Mr.
Cerminara was named to the Board of Directors on February 20, 2015. On September 23, 2015, Mr. Cerminara was appointed as
Executive Chairman. Effective November 24, 2015, Mr. Cerminara was appointed as our Chief Executive Officer. He also continues
to serve as our Executive Chairman. For 2018 and 2017, Mr. Cerminara did not receive any additional compensation as a director
or as Executive Chairman.
|
|
|
(2)
|
Mr.
Roberson was appointed as Executive Vice President and Chief Financial Officer effective November 16, 2018 and was not a Named
Executive Officer in 2017.
|
|
|
(3)
|
Mr.
Schulz was appointed as Senior Vice President, Treasurer and Chief Financial Officer effective March 29, 2017 and served in
that capacity until his resignation effective November 16, 2018.
|
|
|
(4)
|
The
amounts in these columns represent the aggregate grant date fair value calculated in accordance with the Financial Accounting
Standards Board (“FASB”) ASC Topic 718. For additional information relating to the assumptions made in valuing
and expensing these awards refer to Note 12 in the Company’s consolidated financial statements included in the Company’s
Annual Report on Form 10-K for the year ended December 31, 2018, as filed with the SEC.
|
|
|
(5)
|
Consists
of the grant date fair value of the January 26, 2018 grant of 40,000 RSUs to each of Messrs. Cerminara, Schulz and Boegner,
in accordance with the 2017 Omnibus Equity Compensation Plan. RSUs are to be settled in shares of the Company’s common
stock on a one-for-one basis as soon as practicable following the applicable vesting date. The RSUs for Messrs. Cerminara
and Boegner vest in one-third annual installments, beginning on the first anniversary of the grant date, subject to continued
employment. As part of Mr. Schulz’s consulting agreement entered into in connection with his resignation, effective
November 16, 2018, the Company agreed to amend Mr. Schulz’s award agreement to provide that one-third of his RSUs would
vest on January 26, 2019, and two-thirds of his RSUs would vest on March 31, 2019, subject to Mr. Schulz remaining in the
continuous service of the Company through the applicable vesting dates. The fair value of Mr. Schulz’s RSUs as of November
16, 2018, the date of the amendment, was $125,200.
|
|
|
(6)
|
Consists
of the grant date fair value of the February 28, 2017 grant of 60,000 and 10,000 restricted shares of the Company’s
common stock to Messrs. Cerminara and Boegner, respectively, in accordance with the 2010 Long-Term Incentive Plan. The shares
vest in one-third annual installments, beginning on the first anniversary of the grant date, subject to continued employment.
|
|
|
(7)
|
Consists
of the grant date fair value of the December 4, 2018 grant of 50,000 RSUs, in accordance with the 2017 Omnibus Equity Compensation
Plan. RSUs are to be settled in shares of the Company’s common stock on a one-for-one basis as soon as practicable following
the applicable vesting date. The RSUs vest in one-third annual installments, beginning on the first anniversary of the grant
date, subject to continued employment. The RSUs were granted as a signing bonus pursuant to the terms of Mr. Roberson’s
Employment Agreement with the Company.
|
|
|
(8)
|
Consists
of the grant date fair value of the January 26, 2018 grant of 50,000 stock options to each of Messrs. Cerminara, Schulz and
Boegner, in accordance with the 2017 Omnibus Equity Compensation Plan. The stock options vest in one-fifth annual installments,
beginning on the first anniversary of the grant date. Mr. Schulz’s stock options were forfeited upon his resignation
from the Company effective November 16, 2018.
|
(9)
|
Consists
of the grant date fair value of the February 28, 2017 grant of 60,000 and 40,000 stock options to Messrs. Cerminara and Boegner,
respectively, in accordance with the 2010 Long-Term Incentive Plan. The stock options vest in one-fifth annual installments,
beginning on the first anniversary of the grant date.
|
|
|
(10)
|
Consists
of the grant date fair value of the December 4, 2018 grant of 40,000 stock options in accordance with the 2017 Omnibus Equity
Compensation Plan. The stock options vest in one-fifth annual installments, beginning on the first anniversary of the grant
date. The options were granted as a signing bonus pursuant to the terms of Mr.Roberson’s Employment Agreement with the
Company.
|
|
|
(11)
|
Consists
of the grant date fair value of the April 7, 2017 grant of 40,000 stock options in accordance with the 2010 Long-Term Incentive
Plan, which become exercisable in four equal annual installments beginning on the first anniversary of the grant date. The
options were granted as a signing bonus pursuant to the terms of Mr. Schulz’s Employment Agreement with the Company.
Upon his resignation from the Company effective November 16, 2018, Mr. Schulz immediately forfeited 30,000 unvested options
and, following a period of 30 days from the effective date of his resignation, forfeited the right to exercise 10,000 options.
|
|
|
(12)
|
The
Company provides its executives with certain employee benefits. These benefits include excess life and disability insurance
and contributions made by the Company under the Ballantyne Retirement and Savings Plan. The amounts reported for each Named
Executive Officer as All Other Compensation for 2018 are identified and quantified below:
|
|
|
Mr.
Cerminara
|
|
|
Mr.
Roberson
|
|
|
Mr.
Schulz
|
|
|
Mr.
Boegner
|
|
Accrued Vacation Pay-out
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
17,362
|
|
|
$
|
—
|
|
Consulting fees
(1)
|
|
|
—
|
|
|
|
—
|
|
|
|
40,025
|
|
|
|
—
|
|
Employer match on Retirement and Savings
Plan
|
|
|
4,673
|
|
|
|
—
|
|
|
|
7,300
|
|
|
|
8,250
|
|
Excess life and
disability insurance
|
|
|
1,018
|
|
|
|
85
|
|
|
|
933
|
|
|
|
943
|
|
Total All Other
Compensation
|
|
$
|
5,691
|
|
|
$
|
85
|
|
|
$
|
65,620
|
|
|
$
|
9,193
|
|
|
(1)
|
In
connection with his resignation effective November 16, 2018, the Company entered into a consulting agreement with Mr. Schulz.
Pursuant to the consulting agreement, Mr. Schulz agreed to provide consulting services to the Company through March 31, 2019,
at the rate of $26,683 per month, pro-rated for any partial month.
|
The
following table sets forth information concerning outstanding equity awards for each of the Company’s Named Executive Officers
as of the end of the last completed fiscal year.
Outstanding
Equity Awards at 2018 Fiscal Year-End
|
|
Option
Awards
|
|
|
Stock
Awards
|
|
Name
|
|
Number
of Securities Underlying Unexercised Options (#) Exercisable
|
|
|
Number
of Securities Underlying Unexercised Options (#) Unexercisable
|
|
|
Option
Exercise
Price ($)
|
|
|
Option
Expiration Date
|
|
|
Number
of Shares or Units of Stock That Have Not Vested (#)
|
|
|
Market
Value of Shares or Units of Stock That Have Not Vested ($)(*)
|
|
D. Kyle
Cerminara
|
|
|
36,000
|
|
|
|
24,000
|
(1)
|
|
|
4.33
|
|
|
|
11/22/2025
|
|
|
|
—
|
|
|
|
—
|
|
|
|
|
12,000
|
|
|
|
48,000
|
(2)
|
|
|
6.50
|
|
|
|
2/28/2027
|
|
|
|
—
|
|
|
|
—
|
|
|
|
|
—
|
|
|
|
50,000
|
(3)
|
|
|
4.70
|
|
|
|
1/26/2028
|
|
|
|
—
|
|
|
|
—
|
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
40,000
|
(7)
|
|
|
46,000
|
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
40,000
|
(8)
|
|
|
46,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Mark D. Roberson
|
|
|
—
|
|
|
|
40,000
|
(4)
|
|
|
2.25
|
|
|
|
12/4/2028
|
|
|
|
50,000
|
(9)
|
|
|
57,500
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Lance V. Schulz
|
|
|
—
|
|
|
|
—
|
(3)
(5)
|
|
|
—
|
|
|
|
—
|
|
|
|
40,000
|
(10)
|
|
|
46,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ray F. Boegner
|
|
|
5,000
|
|
|
|
—
|
(6)
|
|
|
4.70
|
|
|
|
1/11/2022
|
|
|
|
—
|
|
|
|
—
|
|
|
|
|
16,000
|
|
|
|
16,000
|
(1)
|
|
|
4.33
|
|
|
|
11/22/2025
|
|
|
|
—
|
|
|
|
—
|
|
|
|
|
8,000
|
|
|
|
32,000
|
(2)
|
|
|
6.50
|
|
|
|
2/28/2027
|
|
|
|
—
|
|
|
|
—
|
|
|
|
|
—
|
|
|
|
50,000
|
(3)
|
|
|
4.70
|
|
|
|
1/26/2028
|
|
|
|
—
|
|
|
|
—
|
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
6,667
|
(11)
|
|
|
7,667
|
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
40,000
|
(8)
|
|
|
46,000
|
|
* Based on the closing stock price of our common stock of $1.15 on December 31, 2018, the last trading day of the 2018 fiscal year.
(1)
|
The
60,000 and 40,000 stock options granted to Messrs. Cerminara and Boegner, respectively, on November 22, 2015 pursuant to the
2010 Long-Term Incentive Plan become exercisable in five equal annual installments beginning on November 22, 2016 and thereafter
on November 22, of each year through 2020. On November 23, 2016, Mr. Boegner exercised options from this grant to acquire
8,000 shares of the Company’s common stock at an exercise price of $4.33 per share.
|
|
|
(2)
|
The
60,000 and 40,000 stock options granted to Messrs. Cerminara and Boegner, respectively, on February 28, 2017 pursuant to the
2010 Long-Term Incentive Plan become exercisable in five equal annual installments beginning on February 28, 2018 and thereafter
on February 28 of each year through 2022.
|
|
|
(3)
|
The
50,000 stock options granted to each of Messrs. Cerminara and Boegner on January 26, 2018 become exercisable in five equal
annual installments beginning on January 26, 2019 and thereafter on January 26 of each year through 2023. Mr. Schulz was also
granted 50,000 stock options with the same vesting terms on January 26, 2018. Upon his resignation from the Company effective
November 16, 2018, Mr. Schulz immediately forfeited all 50,000 unvested options.
|
|
|
(4)
|
The
40,000 stock options granted to Mr. Roberson on December 4, 2018 pursuant to the 2017 Omnibus Equity Compensation Plan become
exercisable in five equal annual installments beginning on December 4, 2019 and thereafter on December 4 of each year through
2023.
|
|
|
(5)
|
The
40,000 stock options granted to Mr. Schulz on April 7, 2017 pursuant to the 2010 Long-Term Incentive Plan were scheduled to
vest and become exercisable in four equal annual installments beginning on April 7, 2018 and thereafter on April 7 of each
year through 2021. Upon his resignation from the Company effective November 16, 2018, Mr. Schulz immediately forfeited 30,000
unvested options and, following a period of 30 days from the effective date of his resignation, forfeited the right to exercise
10,000 options.
|
|
|
(6)
|
The
30,000 stock options granted to Mr. Boegner on January 11, 2012 pursuant to the 2010 Long-Term Incentive Plan became exercisable
in four equal installments beginning on January 11, 2013 and thereafter on January 11 of each year through 2016. On both August
11, 2016 and August 30, 2016, Mr. Boegner exercised options from this grant to acquire 5,000 shares of the Company’s
common stock. On June 8, 2017, Mr. Boegner exercised options from this grant to acquire 7,000 shares of the Company’s
common stock. On August 14, 2017, Mr. Boegner exercised options from this grant to acquire 8,000 shares of the Company’s
common stock.
|
|
|
(7)
|
Represents
40,000 shares of restricted stock. The restricted shares vest in equal annual installments on February 27, 2019 and February
27, 2020.
|
|
|
(8)
|
Represents
40,000 RSUs to be settled in shares of the Company’s common stock on a one-for-one basis as soon as practicable following
the applicable vesting date. The RSUs vest in equal annual installments on January 26, 2019, January 26, 2020 and January
26, 2021.
|
|
|
(9)
|
Represents
50,000 RSUs to be settled in shares of the Company’s common stock on a one-for-one basis as soon as practicable following
the applicable vesting date. The RSUs vest in equal annual installments on December 4, 2019, December 4, 2020 and December
4, 2021.
|
|
|
(10)
|
Represents
40,000 RSUs to be settled in shares of the Company’s common stock on a one-for-one basis as soon as practicable following
the applicable vesting date. As part of Mr. Schulz’s consulting agreement entered into in connection with his resignation,
the Company agreed to amend Mr. Schulz’s award agreement for the RSUs held by Mr. Schulz to provide that one-third of
the RSUs would vest on January 26, 2019, and two-thirds of the RSUs would vest on March 31, 2019, subject to Mr. Schulz remaining
in the continuous service of the Company through the applicable vesting dates.
|
|
|
(11)
|
Represents
6,667 shares of restricted stock. The shares vest in equal annual installments on February 27, 2019 and February 27, 2020.
|
Potential
Payments Upon Termination or Change-in-Control
Employment
Agreements
Pursuant
to Mr. Boegner’s employment agreement with the Company, in the event Mr. Boegner’s employment is terminated by the
Company without good cause or by Mr. Boegner for good reason, then he will receive his base salary for a period equal to three
(3) weeks for each year that he has been employed by the Company and all existing insurance benefits shall remain in force until
the last day of the month in which the severance period expires, subject to Mr. Boegner’s continued compliance with certain
restrictive covenants set forth in the employment agreement (including confidentiality and non-solicitation covenants) and his
execution of the Company’s standard form of general release. In addition, Mr. Boegner would be entitled to receive any earned
and unpaid amounts owed to him under the employment agreement and such other accrued benefits as may be provided for under the
agreement. For purposes of Mr. Boegner’s employment agreement, “good reason” means a material breach by the
Company of its obligations to Mr. Boegner under the agreement. In addition, for purposes of the agreement, “cause”
exists if Mr. Boegner (i) acted dishonestly or incompetently or engaged in willful misconduct in performance of his executive
duties, (ii) breached fiduciary duties owed to the Company, (iii) intentionally failed to perform reasonably assigned duties,
(iv) willfully violated any law, rule or regulation, or court order (other than minor traffic violations or similar offenses),
or otherwise committed any act which would have a material adverse impact on the business of the Company, and/or (v) is in breach
of his obligations under the agreement and fails to cure such breach within thirty (30) days after receiving notice of the breach
from the Company.
We
are also obligated under Mr. Boegner’s employment agreement to provide certain payments to Mr. Boegner in the event of his
death or termination by reason of his incapacity. In the event of Mr. Boegner’s death, we are obligated to pay his estate
all accrued sums due and owing to Mr. Boegner with respect to his salary and such other benefits as may be provided under his
agreement. In addition, in the event we terminate Mr. Boegner’s employment by reason of his incapacity, Mr. Boegner is entitled
to any accrued amounts due and owing to him with respect to his salary and such other benefits as may be provided under his agreement.
The
employment agreement for Mr. Roberson does not provide for any specified severance benefits. However, Mr. Roberson, along with
Mr. Cerminara, would have been entitled during the 2018 fiscal year to severance and other benefits, such as accrued vacation,
pursuant to the Company’s then-existing severance policy available to all salaried employees. Mr. Schulz’s employment
agreement did not provide for any specified severance benefits.
2017
Omnibus Equity Compensation Plan – Change in Control Provisions
Our
2017 Omnibus Equity Compensation Plan (the “2017 Plan”), which was approved by our stockholders on June 15, 2017,
generally provides for “double-trigger” vesting of equity awards in connection with a change in control of the Company,
as described below.
To
the extent that outstanding awards granted under the 2017 Plan are assumed in connection with a change in control, except as otherwise
provided in the applicable award agreement or in another written agreement with the participant, all outstanding awards will continue
to vest and become exercisable (as applicable) based on continued service during the remaining vesting period, with performance-based
awards being converted to service-based awards at the “target” level. Vesting and exercisability (as applicable) of
awards that are assumed in connection with a change in control generally would be accelerated in full on a “double-trigger”
basis, if, within two years after the change in control, the participant’s employment is involuntarily terminated without
cause, or by the participant for “good reason.” Any stock options or stock appreciation rights (SARs) that become
vested on a “double-trigger” basis generally would remain exercisable for the full duration of the term of the applicable
award.
To
the extent outstanding awards granted under the 2017 Plan are not assumed in connection with a change in control, then such awards
generally would become vested in full on a “single-trigger” basis, effective immediately prior to the change in control,
with performance-based awards becoming vested at the “target” level. Any stock options or SARs that become vested
on a “single-trigger” basis generally would remain exercisable for the full duration of the term of the applicable
award.
The
Compensation Committee has the discretion to determine whether or not any outstanding awards granted under the 2017 Plan will
be assumed by the resulting entity in connection with a change in control, and the Compensation Committee has the authority to
make appropriate adjustments in connection with the assumption of any awards. The Compensation Committee also has the right to
cancel any outstanding awards in connection with a change in control, in exchange for a payment in cash or other property (including
shares of the resulting entity) in an amount equal to the excess of the fair market value of the shares subject to the award over
any exercise price related to the award, including the right to cancel any “underwater” stock options and SARs without
payment therefor.
For
purposes of the 2017 Plan, subject to the exceptions set forth in the 2017 Plan, a “change in control” generally includes
(a) the acquisition of more than 50% of the voting power or value of the Company’s stock; (b) the incumbent board of directors
ceasing to constitute a majority of the board of directors during a twelve-month period; and (c) the acquisition of 50% or more
of the gross fair market value of the Company’s assets over a twelve-month period. The full definition of “change
in control” is set out in the 2017 Plan.
For
purposes of the 2017 Plan, unless otherwise defined in a written agreement with the participant or an applicable severance plan,
“cause”, as a reason for the Company’s termination of a participant’s employment, generally means that
the participant (a) acted dishonestly or incompetently or engaged in willful misconduct in performance of his or her duties; (b)
breached fiduciary duties owed to the Company; (c) intentionally failed to perform reasonably assigned duties, which the participant
did not satisfactorily correct within 30 calendar days following written notification; (d) was convicted or entered a plea of
guilty or nolo contendere of any felony crime involving dishonesty; or (e) otherwise committed any act which could have a material
adverse impact on the business of the Company.
For
purposes of the 2017 Plan, unless otherwise defined in a written agreement with the participant or an applicable severance plan,
“good reason”, as a reason for a participant’s termination of his or her employment, generally means the occurrence
of any of the following without the participant’s consent (and unless timely cured by the Company following notice from
the participant): (a) any material diminution in the participant’s compensation or benefits, unless generally applicable
to all similarly situated employees of the Company; (b) the assignment to the participant of any duties inconsistent with, or
substantially adverse to his or her status and duties, or a reduction in title; (c) a material breach by the Company or a subsidiary
of its obligations under the participant’s employment agreement, if any; or (d) the relocation of the participant’s
primary work location to a location more than fifty miles away from the current location, in each case if not cured by the Company
within the time limits set forth in the 2017 Plan.
Except
as described above with respect to a change in control, unexercisable stock options, unvested restricted shares and unvested RSUs
generally become forfeited upon termination of employment. The stock options that are exercisable at the time of termination of
employment expire within the earlier of thirty days after such termination or the expiration date of the options. Upon termination
for “cause,” all options, whether or not exercisable, are generally automatically forfeited.
Awards
granted under the 2017 Plan may be subject to forfeiture or recoupment as determined by the Compensation Committee in the event
of certain detrimental activity, such as a participant’s breach of applicable restrictive covenants. Awards granted under
the 2017 Plan also may be subject to forfeiture or recoupment as provided pursuant to any compensation recovery (or “clawback”)
policy that the Company may adopt or maintain from time to time.
2010
Long-Term Incentive Plan – Change in Control Provisions
Our
2010 Long-Term Incentive Plan (the “2010 Plan”) provides that no acceleration of an award shall occur upon or after
a “change in control” unless such acceleration is provided for in the applicable award agreement and determined by
the Compensation Committee on a grant-by-grant basis or as may be provided in an after written agreement between the Company and
the grantee. The award agreements for the stock options, restricted shares and restricted share units granted to Messrs. Cerminara,
Schulz and Boegner under our 2010 Plan provide for accelerated vesting of all unvested options, restricted shares and restricted
share units upon the occurrence of a “change in control” while the grantee is employed by the Company or a subsidiary
of the Company as of the date of the change in control.
For
purposes of the 2010 Plan, subject to the exceptions set forth in the 2010 Plan, a “change in control” generally includes
(i) the acquisition of more than 50% of the company’s common stock; (ii) over a twelve-month period, the acquisition of
more than 50% of the company’s common stock or the replacement of a majority of the board of directors by directors not
endorsed by the persons who were members of the board before the new directors’ appointment; and (iii) the acquisition of
more than 50% of the total gross fair market value of all the assets of the Company over a twelve-month period.
DIRECTOR
COMPENSATION
The
following table sets forth the compensation paid to the Company’s directors in fiscal 2018, except for Mr. Cerminara who
does not receive any separate compensation for his service as a director.
|
|
Fees
Earned Or Paid in
Cash ($)
(1)
|
|
|
Stock
Awards
($)
(3)
|
|
|
Option
Awards
($)
|
|
|
Non-Equity
Incentive Plan Compensation
($)
|
|
|
Change
in Pension Value and Nonqualified Deferred Compensation Earnings
($)
|
|
|
All
Other Compensation
($)
|
|
|
Total
($)
|
|
Samuel C.
Freitag
(2)
|
|
|
31,829
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
31,829
|
|
William J. Gerber
(2)
|
|
|
43,750
|
|
|
|
30,000
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
73,750
|
|
Jack H. Jacobs
(2)
|
|
|
8,195
|
|
|
|
30,000
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
38,195
|
|
Lewis M. Johnson
(2)
|
|
|
32,559
|
|
|
|
30,000
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
62,559
|
|
Charles T. Lanktree
(2)
|
|
|
37,000
|
|
|
|
30,000
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
67,000
|
|
Robert J. Roschman
|
|
|
31,750
|
|
|
|
30,000
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
61,750
|
|
James C. Shay
|
|
|
22,908
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
22,908
|
|
Ndamukong Suh
|
|
|
31,750
|
|
|
|
30,000
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
61,750
|
|
(1)
|
Represents
the annual retainer fee paid to each director and cash payments for attendance at Board meetings and Board committee meetings
both in person and via teleconference. Messrs. Freitag and Shay resigned from the Board effective August 30, 2018 and July
6, 2018, respectively. Colonel Jacobs was appointed to the Board effective July 11, 2018. Each director who served for a partial
year during 2018 received a pro rata portion of the annual cash retainer fee. Although not included in the above table, the
directors are reimbursed for their out-of-pocket expenses of attending Board meetings.
|
|
|
(2)
|
Mr.
Gerber earned $10,000 for acting as Chairman of the Audit Committee, Mr. Lanktree earned $5,000 for acting as Chairman of
the Compensation Committee and Messrs. Freitag, Jacobs and Johnson each earned a pro rata portion of $5,000 for acting as
Chairman of the Nominating and Corporate Governance Committee (Mr. Freitag served as Chairman until Mr. Johnson was appointed
Chairman effective July 11, 2018, and Mr. Johnson served as Chairman from July 11, 2018 until Colonel Jacobs was appointed
Chairman effective September 7, 2018).
|
|
|
(3)
|
On
December 4, 2018, Messrs. Gerber, Jacobs, Johnson, Lanktree, Roschman and Suh were each
granted 13,333 restricted stock units under the 2017 Omnibus Equity Compensation Plan.
The restricted stock units vest on December 4, 2019, subject to the recipient’s
continued service as a director of the Company through such date. Each restricted stock
unit represents a contingent right to receive one share of common stock of the Company.
The amounts shown in this column include the fair value of the annual restricted stock
award on the date of grant, which was $2.25 per share. For additional information relating
to the assumptions made in valuing and expensing these awards for 2018, refer to Note
12 in the Company’s consolidated financial statements included in the Company’s
Annual Report on Form 10-K for the year ended December 31, 2018, as filed with the SEC.
The
aggregate number of unvested restricted stock awards outstanding as of December 31, 2018 for each of Messrs. Gerber, Jacobs,
Johnson, Lanktree, Roschman and Suh was 13,333.
|
Our
non-employee directors receive an annual cash retainer of $25,000, paid in quarterly installments, and the following cash payments
for attending Board meetings and Board committee meetings: (i) $1,500 for each Board meeting attended in person; (ii) $500 for
each Board meeting attended via teleconference; (iii) $500 for each Board committee meeting attended in person; and (iv) $250
for each Board committee meeting attended via teleconference. Each non-employee director also receives an annual grant of restricted
stock units with a value of $30,000. Each restricted stock unit represents a contingent right to receive one share of common stock
of the Company and vests on the one-year anniversary of the grant date. In addition, the Chairman of the Board and the Chairman
of the Audit Committee each receive an annual cash retainer of $10,000, paid in quarterly installments, and the Chairman of the
Compensation Committee and the Chairman of the Nominating and Governance Committee each receive an annual cash retainer of $5,000,
paid in quarterly installments. The non-employee directors also receive reimbursement of reasonable out-of-pocket expenses for
attending Board meetings.
Our
2017 Plan includes a limit on the amount of compensation payable to our non-employee directors. Specifically, the 2017 Plan provides
that the aggregate grant date fair value of all awards granted to any single non-employee director during any single calendar
year (determined as of the applicable grant date(s) under applicable financial accounting rules), when taken together with any
cash fees paid to the non-employee director during the same calendar year, may not exceed $200,000.
Item
12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters
SECURITY
OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
Largest
Owners of Ballantyne Shares
The
following table shows each person or entity that Ballantyne knows to be the beneficial owner of more than five percent of the
Company’s outstanding common stock as of March 15, 2019.
Name
and Address of Beneficial Owner
|
|
Amount
and Nature of Beneficial Ownership
(1)
|
|
|
Percent
of Class
(2)
|
|
Fundamental
Global Investors, LLC
4201
Congress Street, Suite 140
Charlotte,
NC 28209
|
|
|
4,512,444
|
(3)
|
|
|
31.1
|
%
|
Ariel
Investments, LLC
200
E. Randolph Street, Suite 2900
Chicago,
IL 60601
|
|
|
3,582,538
|
(4)
|
|
|
24.7
|
%
|
Dimensional
Fund Advisors LP
6300
Bee Cave Road, Building One
Austin,
TX 78746
|
|
|
1,031,736
|
(5)
|
|
|
7.1
|
%
|
(1)
|
This
information is based on Schedules 13G and 13D, as amended, and a Form 4 filed with the SEC. Fundamental Global Investors,
LLC filed an amended Schedule 13D on March 13, 2019 and an amended Form 4 on January 25, 2019; Ariel Investments, LLC (“Ariel”)
filed an amended Schedule 13G on February 8, 2019; and Dimensional Fund Advisors LP (“Dimensional”) filed an amended
Schedule 13G on February 8, 2019.
|
|
|
(2)
|
Based
upon 14,492,090 shares outstanding on March 15, 2019.
|
|
|
(3)
|
Fundamental
Global Investors, LLC has shared dispositive power over 4,512,444 shares, representing approximately 31.1% of the Company’s
outstanding shares of common stock, and shared voting power over 3,205,209 shares. The number reported in the table includes
the 1,307,235 shares held by CWA Asset Management Group, LLC, a wealth advisor and multi-family office of which Fundamental
Global Investors, LLC owns 50%, for the accounts of individual investors. Additional affiliates of Fundamental Global Investors,
LLC, including Messrs. Cerminara and Johnson, hold 606,528 shares (including 70,000 shares purchasable pursuant to stock options
held by Mr. Cerminara exercisable within 60 days of March 15, 2019), thus increasing the total number of shares beneficially
owned by Fundamental Global Investors, LLC to 5,118,972 shares, or 35.2% of the Company’s outstanding shares of common
stock. Fundamental Global Investors, LLC, on behalf of the funds managed by it, has entered into a stock trading plan in accordance
with Rule 10b5-1 of the Exchange Act (the “10b5-1 Plan”), for the purchase of up to 1.5 million shares of common
stock of the Company. The 10b5-1 Plan becomes effective on April 1, 2019 and will terminate on April 1, 2020 or such earlier
date as set forth in the 10b5-1 Plan. Transactions under the 10b5-1 Plan, if any, will be reported to the SEC in accordance
with applicable securities laws, rules and regulations.
|
|
|
(4)
|
Ariel
reported that it has sole voting power over 3,488,638 shares and sole dispositive power over 3,582,538 shares. Ariel reported
that its adviser clients have the right to receive or the power to direct the receipt of dividends from, or the proceeds from
the sale of, all securities reported as beneficially owned by Ariel.
|
|
|
(5)
|
Dimensional
reported that it has sole voting power over 1,003,003 shares and sole dispositive power over 1,031,736 shares. Dimensional
reported that the funds, group trusts and separate accounts it provides investment management or adviser services to have
the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the securities
held in their respective accounts which are reported as beneficially owned by Dimensional.
|
Share
Ownership of Directors and Officers
The
following chart sets forth, as of the close of business on March 15, 2019, certain information concerning beneficial ownership
of common stock by each director of the Company, each of the named executive officers (as defined below), and all current directors
and executive officers as a group. The address for each director and executive officer listed is: c/o Ballantyne Strong, Inc.,
11422 Miracle Hills Drive, Suite 300, Omaha, NE 68154.
Name
|
|
Number
of Shares Beneficially Owned
(1)
|
|
|
Percent
of Common Stock
(2)
|
|
D. Kyle Cerminara, Chairman
and CEO
|
|
|
4,810,036
|
(3)
|
|
|
33.0
|
%
|
Mark D. Roberson, Executive Vice President
and CFO
|
|
|
2,000
|
(4)
|
|
|
*
|
|
Ray F. Boegner, President of Cinema
|
|
|
188,352
|
(5)
|
|
|
1.3
|
%
|
William J. Gerber, Director
|
|
|
17,241
|
(6)
|
|
|
*
|
|
Jack H. Jacobs, Director
|
|
|
—
|
(7)
|
|
|
*
|
|
Lewis M. Johnson, Director
|
|
|
4,531,534
|
(8)
|
|
|
31.3
|
%
|
Charles T. Lanktree, Director
|
|
|
24,741
|
(9)
|
|
|
*
|
|
Robert J. Roschman, Director
|
|
|
31,629
|
(10)
|
|
|
*
|
|
Ndamukong Suh, Director
|
|
|
18,215
|
(11)
|
|
|
*
|
|
Lance V. Schulz, Former Senior Vice
President, CFO and Treasurer
|
|
|
40,000
|
(12)
|
|
|
*
|
|
All current directors and executive
officers as a group (9 persons)
|
|
|
5,111,304
|
(13)
|
|
|
35.0
|
%
|
*
|
Less
than 1% of common stock outstanding.
|
|
|
(1)
|
Each
director and named executive officer listed above owns all outstanding shares directly and has sole voting and investment
power over such shares unless otherwise specified below.
|
|
|
(2)
|
Based
upon 14,492,090 shares of common stock outstanding as of March 15, 2019. Each named person
is deemed to be the beneficial owner of shares of common stock that may be acquired within
60 days of March 15, 2019 upon the exercise of stock options, as well as shares of common
stock issuable within 60 days of March 15, 2019 upon vesting of restricted stock units.
Accordingly, the number of shares and percentage set forth next to the name of such person,
and all current directors and executive officers as a group, includes shares of directly
owned common stock (including shares of restricted common stock), shares of common stock
issuable pursuant to stock options exercisable within 60 days of March 15, 2019 and shares
of common stock issuable upon the vesting of restricted stock units within 60 days of
March 15, 2019. However, the shares of common stock so issuable upon the exercise of
stock options and/or vesting of restricted stock units held by any such person are not
included in calculating the percentage of common stock beneficially owned by any other
stockholder.
|
|
|
(3)
|
Includes
204,612 shares of common stock directly owned by Mr. Cerminara (including 26,667 restricted shares granted on February 28,
2017), 7,540 shares held in Mr. Cerminara’s 401(k) plan, 15,440 shares held by Mr. Cerminara’s wife and children
and 70,000 shares purchasable pursuant to stock options exercisable within 60 days of March 15, 2019. Also includes 4,512,444
shares of common stock beneficially owned by Fundamental Global Investors, LLC, the largest stockholder of the Company, and
its affiliates (collectively, “Fundamental Global”). Mr. Cerminara, as Chief Executive Officer, Co-Founder and
Partner of Fundamental Global Investors, LLC, is deemed to have shared voting and dispositive power over the shares beneficially
owned by Fundamental Global. Mr. Cerminara disclaims beneficial ownership of the Fundamental Global shares except to the extent
of his pecuniary interest therein. Does not include 26,667 shares potentially issuable to Mr. Cerminara pursuant to restricted
stock units granted on January 26, 2018. Does not include 24,000 shares potentially issuable upon the exercise of stock options
granted on November 22, 2015, 36,000 shares potentially issuable upon the exercise of stock options granted on February 28,
2017 and 40,000 shares potentially issuable upon the exercise of stock options granted on January 26, 2018.
|
(4)
|
Includes
2,000 shares of common stock held directly by Mr. Roberson. Does not include 50,000 shares
potentially issuable to Mr. Roberson pursuant to restricted stock units granted on December
4, 2018. Does not include 40,000 shares potentially issuable upon the exercise of stock
options granted on December 4, 2018.
|
|
|
(5)
|
Includes
141,352 shares of common stock directly owned by Mr. Boegner (including 3,334 restricted shares granted on February 28, 2017)
and 47,000 shares purchasable pursuant to stock options exercisable within 60 days of March 15, 2019. Does not include 26,667
shares potentially issuable pursuant to restricted stock units granted on January 26, 2018. Does not include 16,000 shares
potentially issuable upon the exercise of stock options granted on November 22, 2015, 24,000 shares potentially issuable upon
the exercise of stock options granted on February 28, 2017 and 40,000 shares potentially issuable upon the exercise of stock
options granted on January 26, 2018.
|
|
|
(6)
|
Includes
17,241 shares of common stock directly owned by Mr. Gerber. Does not include 13,333 shares of common stock potentially issuable
upon the vesting of restricted stock units granted December 4, 2018.
|
|
|
(7)
|
Does
not include 13,333 shares of common stock potentially issuable to Colonel Jacobs upon the vesting of restricted stock units
granted December 4, 2018.
|
|
|
(8)
|
Includes
19,090 shares of common stock directly owned by Mr. Johnson, 8.500 of which are held by CWA in a customer account. Also includes
4,512,444 shares of common stock beneficially owned by Fundamental Global, the largest stockholder of the Company. Mr. Johnson,
as President, Co-Founder and Partner of Fundamental Global Investors, LLC, is deemed to have shared voting and dispositive
power over the shares beneficially owned by Fundamental Global. Does not include 13,333 shares of common stock potentially
issuable upon the vesting of restricted stock units granted December 4, 2018.
|
|
|
(9)
|
Includes
17,241 shares of common stock directly owned by Mr. Lanktree and 7,500 shares directly owned by the Donna B. Lanktree Family
Trust, the trustee of which is Donna B. Lanktree, the spouse of Mr. Lanktree. Does not include 13,333 shares of common stock
potentially issuable upon the vesting of restricted stock units granted December 4, 2018.
|
|
|
(10)
|
Includes
31,629 shares of common stock directly owned by Mr. Roschman. Does not include 13,333 shares of common stock potentially issuable
upon the vesting of restricted stock units granted December 4, 2018.
|
|
|
(11)
|
Includes
18,215 shares of common stock directly owned by Mr. Suh. Does not include 13,333 shares
of common stock potentially issuable upon the vesting of restricted stock units granted
December 4, 2018.
|
|
|
(12)
|
Mr.
Schulz, a named executive officer, served as Senior Vice President, Chief Financial Officer and Treasurer of the Company from
March 29, 2017 until November 16, 2018. Consists of 13,333 shares of common stock held by Mr. Schulz directly and 26,667 shares
of common stock issuable upon the vesting of restricted stock units within 60 days of March 15, 2019.
|
|
|
(13)
|
Includes
451,380 shares owned directly by all current directors and executive officers as a group (including 30,001 restricted common
shares), 7,540 shares held in Mr. Cerminara’s 401(k) plan, 15,440 shares held by Mr. Cerminara’s wife and children,
7,500 shares held by the Donna B. Lanktree Family Trust, 117,000 shares purchasable pursuant to stock options exercisable
within 60 days of March 15, 2019 and 4,512,444 shares held by Fundamental Global.
|
EQUITY
COMPENSATION PLANS
The
following table sets forth information regarding our equity compensation plans as of December 31, 2018.
Plan
Category
|
|
Number
of securities to be issued upon exercise of outstanding options, warrants and rights
|
|
|
Weighted
average exercise price of outstanding options, warrants and rights
|
|
|
Number
of securities remaining available for future issuance under equity compensation plans (excluding securities reflected in column
(a))
|
|
|
|
(a)
|
|
|
(b)
|
|
|
(c)
|
|
Equity
compensation plans approved by security holders
|
|
|
1,144,498
|
(1)
|
|
$
|
5.06
|
|
|
|
1,049,156
|
(2)
|
Equity
compensation plans not approved by security holders
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
Total
|
|
|
1,144,498
|
|
|
$
|
5.06
|
|
|
|
1,049,156
|
|
|
(1)
|
Includes
427,000 securities to be issued upon exercise of outstanding options under our 2010 Long-Term Incentive Plan; and 440,000
securities to be issued upon exercise of outstanding options and 277,498 securities to be issued upon vesting of restricted
stock units under our 2017 Omnibus Equity Compensation Plan.
|
|
(2)
|
All
shares available for future issuance are under the 2017 Omnibus Equity Compensation Plan.
|
Item
13. Certain Relationships and Related Transactions, and Director Independence
RELATED
PERSON TRANSACTION PROCEDURES
The
Company’s Audit Committee Charter requires the Audit Committee to review policies and procedures regarding transactions
between the Company and officers and directors that are not a normal part of the Company’s business. There are no formal
written policies or procedures used by Board or the Audit Committee to review, approve or ratify related party transactions. Rather,
the Board or the Audit Committee reviews all related party transactions on a case by case basis for potential conflict of interest
situations on an ongoing basis and uses its discretion in approving all such transactions. The Board or the Audit Committee will
apply the standards of Item 404(a) of Regulation S-K when evaluating certain relationships and related transactions.
On
an annual basis, the Company determines whether there are any related party transactions that need to be evaluated and approved
by the Board or the Audit Committee based on the responses received from each director and executive officer based on his questionnaire
completed in conjunction with the Form 10-K/A. While there are no formal written policies or procedures used, the Board or the
Audit Committee may consider the following factors in evaluating related party transactions:
|
●
|
the
nature of the related person’s interest in the transaction;
|
|
|
|
|
●
|
the
presence of standard prices, rates, charges or terms otherwise consistent with arms-length dealings with unrelated third parties;
|
|
|
|
|
●
|
the
materiality of the transaction to each party;
|
|
|
|
|
●
|
the
reasons for the Company entering into the transaction with the related person;
|
|
|
|
|
●
|
the
potential effect of the transaction on the status of a director as an independent, outside or disinterested director or committee
member; and
|
|
|
|
|
●
|
any
other factors the Board or the Audit Committee may deem relevant.
|
All
of the arrangements discussed below have been approved by the Audit Committee and/or the independent members of our Board of Directors.
StrongVest
Global Advisors, LLC
StrongVest
Global Advisors, LLC (“StrongVest”), a wholly-owned subsidiary of the Company, is the investment advisor to CWA Income
ETF (the “Fund”), an exchange-traded fund and series of StrongVest ETF Trust (the “Trust”). CWA Asset
Management Group, LLC (doing business as “Capital Wealth Advisors”) (“CWA”), which is 50% owned by Fundamental
Global Investors, LLC (“FGI”), the largest stockholder of the Company, is the sub-advisor to the Fund. Mr. Cerminara,
Chief Executive Officer and Chairman of the Company, is Chief Executive Officer, Co-Founder and Partner of FGI and Co-Chief Investment
Officer of CWA, and Mr. Johnson, a director of the Company, is President, Co-Founder and Partner of FGI and Co-Chief Investment
Officer of CWA. Messrs. Cerminara and Johnson are managing members of FGI, and each owns a 33.3% ownership interest in FGI.
The
executive officers, employees and directors of the Company hold various positions with StrongVest and the Trust. Mr. Cerminara,
Chief Executive Officer and Chairman of the Company, serves as President, Principal Executive Officer and Trustee of the Trust
and Chief Executive Officer of StrongVest. Ryan R.K. Turner, an employee of the Company, serves as President of StrongVest. John
Puglia, an employee of the Company, serves as Treasurer and Principal Financial Officer of the Trust and as Treasurer and Secretary
of StrongVest (which positions were previously held by Mr. Schulz, former Chief Financial Officer of the Company), and Mr. Jeffrey
L. Sutton, an employee of the Company, also serves as Chief Compliance Officer of StrongVest and as Chief Compliance Officer and
Secretary of the Trust.
Pursuant
to an investment advisory agreement between the Fund and StrongVest (the “Advisory Agreement”), the Fund pays StrongVest
a unitary fee for the services it provides payable on a monthly basis at the annual rate of 0.75% of the Fund’s average
daily net assets, which fee was $64,993 and $38,638 in fiscal 2018 and fiscal 2017, respectively. Out of the unitary management
fee, StrongVest is obligated to pay or arrange for the payment of substantially all expenses of the Fund, including the cost of
transfer agency, custody, fund administration, legal, audit and other services and the fees and expenses of independent trustees
(“Fund Expenses”), except for interest expenses, distribution fees or expenses, brokerage expenses, taxes and extraordinary
expenses such as litigation and other expenses not incurred in the ordinary course of the Fund’s business. StrongVest’s
unitary management fee is designed to cause substantially all of the Fund’s expenses to be paid and to compensate StrongVest
for providing services for the Fund. Pursuant to a sub-advisory agreement between StrongVest and CWA (the “Sub-Advisory
Agreement”), StrongVest is obligated to pay CWA a fee for the services it provides payable on a monthly basis equal to 50%
of the advisory fee that the Fund pays StrongVest (net of the Fund Expenses paid by StrongVest). Because Fund Expenses paid by
StrongVest have exceeded 50% of the advisory fee that the Fund pays StrongVest, StrongVest has not yet paid any amounts to CWA
pursuant to this arrangement.
Blueharbor
Bank
On
April 27, 2017, we entered into a debt agreement with blueharbor bank consisting of (1) a $2.0 million five-year term loan secured
by a first lien deed of trust on our Alpharetta, GA facility, bearing interest at a fixed rate of 4.5% and payable in equal monthly
installments of principal and interest calculated based on a 20-year amortization schedule with a final balloon payment of approximately
$1.7 million due on May 10, 2022, and (2) a line of credit of up to $1.0 million secured by a second lien deed of trust on our
Alpharetta, GA facility, bearing interest at the Prime Rate published in the Wall Street Journal plus 0.25% (4.75% at December
31, 2017) and with a term ending May 10, 2018. On April 23, 2018, we entered into an agreement with blueharbor bank to extend
the maturity date of the $1.0 million line of credit to May 10, 2019. Under the debt agreement, we were required to maintain a
ratio of total liabilities to tangible net worth not in excess of 3 to 1 and maintain minimum liquidity of $2.0 million. At December
31, 2017, the balance of the term loan including current maturities was $2.0 million. We also had outstanding borrowings on our
line of credit of $0.5 million and had the ability to borrow up to an additional $0.5 million. As of December 31, 2017, we were
in compliance with our debt covenants
.
During the year ended December 31, 2017, the Company repaid approximately $32,000
of principal on the term loan and paid an aggregate of $66,000 of interest under the debt agreement.
On
June 29, 2018, we closed a sale-leaseback transaction of our Alpharetta, GA facility pursuant to which we sold the facility to
Metrolina Alpharetta, LLC (“Metrolina”), a third party, for a purchase price of $7.0 million, with the Company simultaneously
leasing the facility back pursuant to a 10-year lease agreement at an annual base rent equal to $600,000 during the first year
of the lease term, with the annual rent thereafter increasing annually by 2%. As part of the closing, we issued ten-year warrants
to Metrolina to purchase up to 100,000 shares of our common stock pursuant to a warrant agreement. At the closing, approximately
$2.94 million of the sale proceeds was used to repay all outstanding amounts owed under, and to terminate, the $2.0 million five-year
term loan and the line of credit of up to $1.0 million with blueharbor bank secured by the Alpharetta facility. Prior to the closing
of the sale-leaseback, we had repaid approximately $32,000 in principal on the term loan during 2018. We paid an aggregate of
$$68,000 of interest under the debt agreement in 2018.
Mr.
Cerminara, our Chairman and Chief Executive Officer, is a member of the board of directors of blueharbor bank. In addition, the
funds managed by Fundamental Global Investors, LLC, of which Mr. Cerminara is the Chief Executive Officer, Co-Founder and Partner,
and Mr. Johnson, a member of our Board of Directors, is the President, Co-Founder and Partner, and its affiliates together beneficially
own less than five percent of the stock of blueharbor bank. The independent members of our Board of Directors approved our debt
agreement with blueharbor bank.
Fundamental
Global Investors, LLC
On
September 9, 2018, the Company entered into a letter agreement with Fundamental Global Investors, LLC, pursuant to which the Company
sold 1,147,087 shares of common stock of BK Technologies, Inc. to funds managed by, and other affiliates of, Fundamental Global
Investors, LLC, at a price of $3.95 per share, which represented the immediately preceding closing price on the NYSE American
stock exchange. The gross proceeds to the Company were approximately $4,530,994. Mr. Cerminara, the Company’s Chairman and
Chief Executive Officer, is the Chief Executive Officer, Co-Founder and Partner of Fundamental Global Investors, LLC, and Mr.
Johnson, a director of the Company, is the President, Co-Founder and Partner of Fundamental Global Investors, LLC. The transaction
was approved by the Audit Committee of the Company, comprised of only independent directors.
DIRECTOR
INDEPENDENCE
The
Board of Directors is composed of a majority of independent directors as defined by the listing requirements of the NYSE American.
The Board of Directors has determined that Messrs. Gerber, Jacobs, Lanktree, Roschman and Suh are independent directors of the
Company under the listing standards adopted by the NYSE American. The Board of Directors also determined that Messrs. Freitag
and Shay, who served on the Board during 2018, were independent under the same listing standards. In making these independence
determinations, the Board considered all of the factors that automatically compromise director independence as specified in the
NYSE American’s listing standards and determined that none of those conditions existed. In addition, the Board considered
whether any direct or indirect material relationship, beyond those factors that automatically compromise director independence,
existed between those directors, their immediate family members, or their affiliated entities, on the one hand, and us and our
subsidiaries, on the other hand. The Board determined, for those directors identified as independent above, that any relationship
that existed was not material and did not compromise that director’s independence. Our independent directors meet in an
executive session at least once per year. All committee members are independent for the purpose of the committees on which they
serve.
Item
14. Principal Accounting Fees and Services
BDO
USA, LLP (“BDO”) has served as the Company’s independent registered public accounting firm since 2016. The following
table sets forth the aggregate fees for professional service rendered by BDO for each of the last two fiscal years:
|
|
2018
|
|
|
2017
|
|
Audit Fees
(1)
|
|
$
|
482,500
|
|
|
$
|
482,800
|
|
Audit-Related Fees
(2)
|
|
|
18,643
|
|
|
|
15,344
|
|
Tax Fees
|
|
|
—
|
|
|
|
—
|
|
All Other Fees
|
|
|
—
|
|
|
|
—
|
|
Total
|
|
$
|
501,143
|
|
|
$
|
498,144
|
|
(1)
|
Includes
fees for professional services rendered during the fiscal year for the audit of our annual financial statements and for reviews
of the financial statements included in our quarterly reports on Form 10-Q. In addition, includes fees for professional services
rendered by BDO USA, LLP related to the review of the Company’s filing of equity method investment financial statements
and issuance of the related consent in 2018, state regulatory filing requirements in 2017 and review of the Company’s
registration statement on Form S-8 and the issuance of the related consent in 2017.
|
|
|
(2)
|
Includes
fees for professional services rendered for the review of standalone financial statements for one of the Company’s subsidiaries.
|
The
Audit Committee has implemented pre-approval procedures consistent with the rules adopted by the SEC. All audit and permitted
non-audit services are pre-approved by the Committee. The Committee has delegated the responsibility of approving proposed non-audit
services that arise between Committee meetings to the Chairman, provided that the decision to approve the services is presented
for ratification at the next scheduled Committee meeting.